ICARES Medicus (ROCO:6612) Cyclically Adjusted PB Ratio: (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6612 ICARES Medicus Inc ROCO:6612
85 GF Score
Price NT$73.10
GF Value NT$173.02
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ICARES Medicus Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ICARES Medicus  (ROCO:6612) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


ICARES Medicus Cyclically Adjusted PB Ratio Related Terms


ICARES Medicus Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for ICARES Medicus's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICARES Medicus Cyclically Adjusted PB Ratio Chart

ICARES Medicus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 3.38

ICARES Medicus Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.44 4.38 3.38 2.96 0.00

ROCO:6612 vs ISRG, BDX, MDLN: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, ICARES Medicus's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ICARES Medicus Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where ICARES Medicus's Cyclically Adjusted PB Ratio falls into.


ROCO:6612
85GF Score
ICARES Medicus Inc ROCO:6612
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ICARES Medicus Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

ICARES Medicus's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, ICARES Medicus's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=39.764/333.9520*333.9520
=39.764

Current CPI (Jun. 2026) = 333.9520.

ICARES Medicus Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 241.428 0.000
201612 8.244 241.432 11.403
201703 0.000 243.801 0.000
201706 8.607 244.955 11.734
201709 9.192 246.819 12.437
201712 9.045 246.524 12.253
201803 10.209 249.554 13.662
201806 10.725 251.989 14.213
201809 13.945 252.439 18.448
201812 14.000 251.233 18.610
201903 14.073 254.202 18.488
201906 14.495 256.143 18.898
201909 15.106 256.759 19.648
201912 15.076 256.974 19.592
202003 15.199 258.115 19.665
202006 15.289 257.797 19.805
202009 15.792 260.280 20.262
202012 16.106 260.474 20.649
202103 16.249 264.877 20.486
202106 16.442 271.696 20.209
202109 16.994 274.310 20.689
202112 17.938 278.802 21.486
202203 18.051 287.504 20.967
202206 18.844 296.311 21.238
202209 20.710 296.808 23.302
202212 20.988 296.797 23.615
202303 20.811 301.836 23.025
202306 22.050 305.109 24.134
202309 23.976 307.789 26.014
202312 33.302 306.746 36.256
202403 34.259 312.332 36.630
202406 35.054 314.175 37.261
202409 33.293 315.301 35.262
202412 35.034 315.605 37.071
202503 36.311 319.799 37.918
202506 33.753 322.561 34.945
202509 36.941 324.800 37.982
202512 38.615 324.054 39.794
202603 39.684 330.213 40.133
202606 39.764 333.952 39.764

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is ICARES Medicus (ROCO:6612) Overvalued in 2026?

Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued. The current stock price of NT$73.10 is trading 57.8% below its estimated GF Value™ of NT$173.02. GuruFocus considers ICARES Medicus to be Possible Value Trap.

Key valuation signals for ROCO:6612:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$173.02 vs. price of NT$73.10 (57.8% below fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ICARES Medicus Business Description

Address Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
85GF Score

Get the complete analysis for ROCO:6612

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$73.10
Price
NT$173.02
GF Value